Online inquiry

IVTScrip™ mRNA-Human ANKRD54, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17931MR)

This product GTTS-WK17931MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD54 protein. This product can be used in Ciliated epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001349853.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 129138
UniProt ID Q6NXT1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD54, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17931MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK27080MR IVTScrip™ mRNA-Human ARHGAP1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP1
GTTS-WK23812MR IVTScrip™ mRNA-Human ARHGEF19, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF19
GTTS-WK13928MR IVTScrip™ mRNA-Human ACKR4, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ACKR4
GTTS-WK28320MR IVTScrip™ mRNA-Human ARHGEF4, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGEF4
GTTS-WK16128MR IVTScrip™ mRNA-Human ANKRD46, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD46
GTTS-WK26711MR IVTScrip™ mRNA-Human APLNR, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA APLNR
GTTS-WK24394MR IVTScrip™ mRNA-Human ARHGAP3, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGAP3
GTTS-WK11604MR IVTScrip™ mRNA-Human ADAMTS5, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADAMTS5
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW